The comparative Next-Generation Sequencing (NGS) analysis between normal tissue and the two distinct tumor areas (A1 and A2) revealed relevant molecular features other than the loss of heterozygosity (LOH) of BRCA2 gene and the 3p21.31 chromosomal sub-band where the MLH1 gene is located (Table 1). This evidence concerns the gene BRCA2 and neoplasm.